Clinical Trial Update: A Composite MR Neuroimaging Marker for Alzheimer's Disease

View source ↗

Summary

The clinical trial evaluating a composite MR neuroimaging marker for Alzheimer's disease and related cognitive impairment has been withdrawn. The listed conditi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Frontotemporal Dementia

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Status: WITHDRAWN